Verticals/Pharma Manufacturing

Pharma Manufacturing

Process, scale-up and the realities of the factory floor — from continuous lines to single-use systems.

ContinuousScale-upTech transferQuality
The Data Bottleneck: Current Limitations of AI in Small Molecule SynthesisArticle
Lead story

The Data Bottleneck: Current Limitations of AI in Small Molecule Synthesis

AI drug discovery models are limited by data, not algorithms, publication bias, narrow chemical space, poor annotation.

Mrudula Kulkarni · Jun 30, 2026
A Guide on Industrial Mixing Tank Stirrer Specification
Article

A Guide on Industrial Mixing Tank Stirrer Specification

Impeller selection, P/V, surface finish, ATEX, CIP/SIP — the complete industrial mixing tank specifications with stirrer systems for pharma engineers.

Mrudula Kulkarni · Jul 2, 2026
The Great Pharma Manufacturing Shift: Why Localisation Matters More Than Ever
Article

The Great Pharma Manufacturing Shift: Why Localisation Matters More Than Ever

Pharma supply chain resilience now demands localisation, why regional manufacturing is shifting from contingency to core strategy.

Vaibhavi M. · Jul 1, 2026
Why Data Quality Has Become Pharma Manufacturing's Most Valuable Asset?
Article

Why Data Quality Has Become Pharma Manufacturing's Most Valuable Asset?

Data quality has shifted from compliance checkbox to pharma's biggest strategic asset, ALCOA+ explains why.

Simantini Singh Deo · Jun 29, 2026
LIMS Implementation In Indian Pharma: A Practical Guide
Article

LIMS Implementation In Indian Pharma: A Practical Guide

LIMS implementation in pharma fails on trust, not technology, why workflow mismatch creates hidden compliance risk.

Mrudula Kulkarni · Jun 27, 2026
Digital Twin in Pharma Manufacturing: From Simulation to Validated Reality
Article

Digital Twin in Pharma Manufacturing: From Simulation to Validated Reality

Digital twin is delivering real ROI in pharma manufacturing. The question in 2026 is not deployment — it's regulatory defensibility.

Mrudula Kulkarni · Jun 27, 2026
Pharma Serialization And Track-And-Trace: A Compliance Guide For 2026
Article

Pharma Serialization And Track-And-Trace: A Compliance Guide For 2026

Pharma serialization and track-and-trace keep shifting for Indian exporters why infrastructure beats one-time projects in 2026.

Mrudula Kulkarni · Jun 26, 2026
Electronic Batch Records: The Real Cost of Staying on Paper
Article

Electronic Batch Records: The Real Cost of Staying on Paper

Paper batch records compound hidden costs every quarter. EBR is harder than it looks — and the data integrity gap is widening.

Mrudula Kulkarni · Jun 26, 2026
CSV to CSA: The Migration Playbook Indian Pharma Hasn't Written Yet
Article

CSV to CSA: The Migration Playbook Indian Pharma Hasn't Written Yet

A 4-step playbook for migrating from CSV to CSA, risk-tiering, retain/retire decisions, and inspection defense for Indian pharma.

Mrudula Kulkarni · Jun 25, 2026
Why 7 of 10 Pharma MES Projects Fail | What the Survivors Do Differently
Article

Why 7 of 10 Pharma MES Projects Fail | What the Survivors Do Differently

7 of 10 pharma MES projects get worked around in two years. Here's why, what survivors do differently, and where it's discussed at PMITS, 7 July.

Mrudula Kulkarni · Jun 25, 2026